Daré Bioscience, Inc. (DARE)
0.8176
+0.02
(+2.01%)
USD |
NASDAQ |
Aug 25, 11:27
Daré Bioscience Debt to Equity Ratio : -12.08 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.08 |
| March 31, 2026 | 9.780 |
| December 31, 2025 | 2.834 |
| September 30, 2025 | 2.856 |
| June 30, 2025 | -0.6361 |
| March 31, 2025 | -0.8789 |
| September 30, 2024 | -3.97 |
| June 30, 2024 | 2.183 |
| March 31, 2024 | -0.5241 |
| December 31, 2023 | -1.054 |
| September 30, 2023 | -0.085 |
| June 30, 2023 | -0.1086 |
| March 31, 2023 | 0.079 |
| December 31, 2022 | 0.044 |
| September 30, 2022 | 0.0221 |
| June 30, 2022 | 0.0347 |
| March 31, 2022 | 0.0391 |
| December 31, 2021 | 0.007 |
| September 30, 2021 | 0.012 |
| June 30, 2021 | 0.0636 |
| March 31, 2021 | 0.183 |
| December 31, 2020 | -0.6571 |
| September 30, 2020 | -0.6205 |
| June 30, 2020 | 3.082 |
| March 31, 2020 | 0.2142 |
| Date | Value |
|---|---|
| December 31, 2019 | 1.816 |
| September 30, 2019 | 0.1012 |
| June 30, 2019 | 0.0401 |
| March 31, 2019 | 0.059 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.9779 |
| September 30, 2016 | 0.8871 |
| June 30, 2016 | 0.645 |
| March 31, 2016 | 0.5147 |
| December 31, 2015 | 0.417 |
| September 30, 2015 | 0.2483 |
| June 30, 2015 | 0.2124 |
| March 31, 2015 | 0.3567 |
| December 31, 2014 | 0.0689 |
| September 30, 2014 | 0.0749 |
| June 30, 2014 | 0.0817 |
| March 31, 2014 | -1.471 |
| December 31, 2013 | 0.2571 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Nektar Therapeutics | 0.1505 |
| Elite Pharmaceuticals, Inc. | 0.0532 |
| Eton Pharmaceuticals, Inc. | 0.6273 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 22.37M |
| Total Liabilities (Quarterly) | 22.93M |
| Shareholders Equity (Quarterly) | -0.5601M |
| Current Ratio | 0.986 |
| Net Debt Paydown Yield | 1.03% |